
Blood Testing Market Growth, Size, Trends Analysis - By Test Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
Blood Testing Market Introduction and Overview
According to SPER market research, ‘Blood Testing Market Size- By Test Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Blood Testing Market is predicted to reach 231.27 billion by 2034 with a CAGR of 9.09%.
A blood test is a simple check-up and a common way to diagnose diseases. The results help doctors identify illnesses and recommend treatment. A blood sample from the patient is tested in a lab for various tests, like glucose and cholesterol tests. Doctors choose tests based on health-related issues for accurate diagnosis. The popularity of blood tests is growing worldwide.
Restraints: The growing number of blood test errors that result in altered final results because of erroneous variations in blood cells may limit market growth to some degree. Depending on the test type, some scans or test results are not entirely standardized. For example, 50% of test results in mammograms used to diagnose breast cancer are erroneous because mammograms are not commonly used to identify breast cancer.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Test Type.
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Companies Covered
Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, bioMerieux, Quest Diagnostics Incorporated, Biomerica, BD, Siemens Healthineers AG, Danaher Corporation, Trinity Biotech Plc.
Blood Testing Market Segmentation:
By Test Type: Based on the Test Type, Global Blood Testing Market is segmented as; Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone, Serum Nicotine/Cotinine, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
According to SPER market research, ‘Blood Testing Market Size- By Test Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Blood Testing Market is predicted to reach 231.27 billion by 2034 with a CAGR of 9.09%.
A blood test is a simple check-up and a common way to diagnose diseases. The results help doctors identify illnesses and recommend treatment. A blood sample from the patient is tested in a lab for various tests, like glucose and cholesterol tests. Doctors choose tests based on health-related issues for accurate diagnosis. The popularity of blood tests is growing worldwide.
Restraints: The growing number of blood test errors that result in altered final results because of erroneous variations in blood cells may limit market growth to some degree. Depending on the test type, some scans or test results are not entirely standardized. For example, 50% of test results in mammograms used to diagnose breast cancer are erroneous because mammograms are not commonly used to identify breast cancer.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Test Type.
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Companies Covered
Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, bioMerieux, Quest Diagnostics Incorporated, Biomerica, BD, Siemens Healthineers AG, Danaher Corporation, Trinity Biotech Plc.
Blood Testing Market Segmentation:
By Test Type: Based on the Test Type, Global Blood Testing Market is segmented as; Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone, Serum Nicotine/Cotinine, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
Table of Contents
228 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Blood Testing Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Blood Testing Market
- 7. Global Blood Testing Market, By Test Type (USD Million) 2021-2034
- 7.1. Glucose Testing
- 7.2. A1 C Testing
- 7.3. Direct LDL Testing
- 7.4. Lipid Panel Testing
- 7.5. Prostate-specific Antigen Testing
- 7.6. COVID-19 Testing
- 7.7. BUN Testing
- 7.8. Vitamin-D Testing
- 7.9. Thyroid-stimulating Hormone (TSH)
- 7.10. Serum Nicotine/Cotinine
- 7.11. High sensitivity CRP Testing
- 7.12. Testosterone Testing
- 7.13. ALT Testing
- 7.14. Cortisol Testing
- 7.15. Creatinine Testing
- 7.16. AST Testing
- 7.17. Others Blood Tests
- 8. Global Blood Testing Market, (USD Million) 2021-2034
- 8.1. Global Blood Testing Market Size and Market Share
- 9. Global Blood Testing Market, By Region, (USD Million) 2021-2034
- 9.1. Asia-Pacific
- 9.1.1. Australia
- 9.1.2. China
- 9.1.3. India
- 9.1.4. Japan
- 9.1.5. South Korea
- 9.1.6. Rest of Asia-Pacific
- 9.2. Europe
- 9.2.1. France
- 9.2.2. Germany
- 9.2.3. Italy
- 9.2.4. Spain
- 9.2.5. United Kingdom
- 9.2.6. Rest of Europe
- 9.3. Middle East and Africa
- 9.3.1. Kingdom of Saudi Arabia
- 9.3.2. United Arab Emirates
- 9.3.3. Qatar
- 9.3.4. South Africa
- 9.3.5. Egypt
- 9.3.6. Morocco
- 9.3.7. Nigeria
- 9.3.8. Rest of Middle-East and Africa
- 9.4. North America
- 9.4.1. Canada
- 9.4.2. Mexico
- 9.4.3. United States
- 9.5. Latin America
- 9.5.1. Argentina
- 9.5.2. Brazil
- 9.5.3. Rest of Latin America
- 10. Company Profile
- 10.1. Abbott
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
- 10.2. F. Hoffmann-La Roche Ltd
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
- 10.3. Bio-Rad Laboratories, Inc
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
- 10.4. bioMerieux
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
- 10.5. Quest Diagnostics Incorporated
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
- 10.6. Biomerica
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
- 10.7. BD
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
- 10.8. Siemens Healthineers AG
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
- 10.9. Danaher Corporation
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
- 10.10. Trinity Biotech Plc
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
- 10.11. Others
- 11. Conclusion
- 12. List of Abbreviations
- 13. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.